# AJES Pharmaceuticals, LLC - Inspection Records

Source: https://www.keypedia.com/companies/ajes-pharmaceuticals-llc/4cf8708e-38cc-444a-84c3-5dde5f13721e

> Inspection records and compliance data for AJES Pharmaceuticals, LLC in Copiague, New York. Access full analysis and detailed observations.

---

## Details

- Name: AJES Pharmaceuticals, LLC
- FEI Number: 3001848656
- City: Copiague
- State: New York
- Country Name: United States
- Address Line 1: 11 Lincoln St
- Zip Code: 11726

## Related Documents

- [FDA Inspection 1262754 - AJES Pharmaceuticals, LLC - 2025-02-07](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/c752aca8-cc5b-4e30-8ae4-45198e349095) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1262754 - AJES Pharmaceuticals, LLC - 2025-02-07](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/63a7152f-721a-4832-a306-80bfca6e57d0) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1253074 - AJES Pharmaceuticals, LLC - 2024-12-09](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/2d8fe8b5-24de-47a0-b62e-c4f79e4b6e5b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2024
- [FDA Inspection 1253074 - AJES Pharmaceuticals, LLC - 2024-12-09](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/a17ef49c-dfd5-4f32-b79e-177c9f8b47be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2024
- [483 - AJES Pharmaceuticals, LLC - 2022-11-21](https://www.keypedia.com/records/483/ajes-pharmaceuticals-llc/343bb849-0e6e-48ce-9d93-e55be6a74f82) — source: FDA, date: November 21, 2022
- [FDA Inspection 1191048 - AJES Pharmaceuticals, LLC - 2022-11-21](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/2756a51b-755c-4781-a023-0878edeb9ddc) — classification: No Action Indicated (NAI), source: FDA, date: November 21, 2022
- [FDA Inspection 1191048 - AJES Pharmaceuticals, LLC - 2022-11-21](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/e0cb5384-a2dd-4203-8e16-0a630d98eaeb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2022
- [483 - AJES Pharmaceuticals, LLC - 2021-10-14](https://www.keypedia.com/records/483/ajes-pharmaceuticals-llc/87ce17f9-36ed-4d68-90a8-40f1a38d6ba8) — source: FDA, date: October 14, 2021
- [FDA Inspection 1155111 - AJES Pharmaceuticals, LLC - 2021-10-14](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/223cd3e9-f2a6-49b5-8ef9-b08167c30694) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 14, 2021
- [FDA Inspection 1155111 - AJES Pharmaceuticals, LLC - 2021-10-14](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/74047a25-8fa0-4313-8f5e-3f4f9c592e4b) — classification: No Action Indicated (NAI), source: FDA, date: October 14, 2021
- [EIR - AJES Pharmaceuticals, LLC - 2018-03-29](https://www.keypedia.com/records/eir/ajes-pharmaceuticals-llc/8b64c15d-35e8-4569-a6f1-d555f93c8eb6) — source: FDA, date: March 29, 2018
- [483 - AJES Pharmaceuticals, LLC - 2018-03-29](https://www.keypedia.com/records/483/ajes-pharmaceuticals-llc/6619e0de-6689-4275-9d2c-76410ccbcb6b) — source: FDA, date: March 29, 2018
- [FDA Inspection 1046683 - AJES Pharmaceuticals, LLC - 2018-03-29](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/87b384a8-0318-4407-b728-b80cb8c95e30) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2018
- [FDA Inspection 962200 - AJES Pharmaceuticals, LLC - 2016-03-09](https://www.keypedia.com/records/fda_inspections/ajes-pharmaceuticals-llc/85649561-faae-4c11-9e22-d80abd79bdf6) — classification: Official Action Indicated (OAI), source: FDA, date: March 9, 2016

## Related Companies

- [Milupa GmbH](https://www.keypedia.com/companies/milupa-gmbh/a406d6b0-df46-4822-8cfb-732831ba1f7c)
- [WHPM Inc.](https://www.keypedia.com/companies/whpm-inc/713384b0-f0ac-4ea2-8216-fc8b0910359b)
- [Transdermal Cap Inc.](https://www.keypedia.com/companies/transdermal-cap-inc/04de6863-f166-4f39-af50-2e3af20c851d)
- [McGuff Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6)
- [Garcia Fresh Vegetables LLC](https://www.keypedia.com/companies/garcia-fresh-vegetables-llc/5fcfb287-f182-4313-a852-1e1c86ab14ca)
- [Future Diagnostics Solutions B.V.](https://www.keypedia.com/companies/future-diagnostics-solutions-bv/6dec2eda-03d3-4e3d-968d-92eb968caf48)
- [Magic Science Supply LLC](https://www.keypedia.com/companies/magic-science-supply-llc/5aa354ed-0445-484e-b0e6-5d952ba4f82c)
- [Optim LLC](https://www.keypedia.com/companies/optim-llc/70fcf768-48ba-4bb3-b22b-a5c3421e1df6)
- [University Of Michigan - IRBMED](https://www.keypedia.com/companies/university-of-michigan-irbmed/2de0ec10-b613-4e4d-9f4a-da48d309f8ca)
- [TBN Labs, LLC.](https://www.keypedia.com/companies/tbn-labs-llc/18ef6dc7-29ad-434e-9b7e-fb7c58b60ce7)

## Related Officers

- [Investigator](https://www.keypedia.com/people/meredith-p-soehl/52252b59-8f03-41e4-a86f-b92c98048023)
- [company_representative](https://www.keypedia.com/people/asha-patel/afa49652-e272-4d87-bf63-8493c6efcee0)
- [investigator](https://www.keypedia.com/people/christopher-s-fields/066519e8-20eb-4c41-aaf6-5b17348a0409)